On Monday, GSK (NYSE: GSK), the British drugmaker, said it would pay up to $1.15 billion to buy Boston-based biopharmaceutical
1 year ago
China’s Zhifei will pay GSK (NYSE: GSK) about 2.3 billion pounds ($2.9 billion) for the exclusive rights to distribute GSK’s
On Wednesday, GSK (NYSE: GSK) said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory
GlaxoSmithKline (NYSE: GSK), the British drugmaker, sued Moderna (NASDAQ: MRNA) in U.S. federal court in Delaware on Tuesday, accusing it
Shares of GSK (NYSE: GSK) rose about 6% on Wednesday after the British drugmaker struck a $2.2 billion settlement over
U.S. sales of RSV vaccines from GSK (NYSE: GSK) and Pfizer (NYSE: PFE) are down significantly after regulators narrowed the
LONDON – On Monday, Pfizer (NYSE: PFE) won a bid in a London court to invalidate two of GSK’s (NYSE:
GSK (NYSE: GSK), Sanofi (NASDAQ: SNY), and CSL Ltd have secured $72 million from the U.S. government to ramp up
On Wednesday, GSK (NYSE: GSK), the British drugmaker, said it had agreed to settle two lawsuits in California that claimed
On Thursday, GSK (NYSE: GSK), the British drugmaker, announced positive results from a mid-stage trial of its seasonal influenza vaccine
On Friday, British drugmaker GSK (NYSE: GSK) said it would seek a dismissal of an upcoming Zantac case in Florida,
FRANKFURT – On Thursday, Germany’s influential vaccine advisory panel said that everyone in the country who is 75 years old
2 years ago
